Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects
Clinical trial NCT04802837 · TERMINATED
Trial details
- NCT number
- NCT04802837
- Sponsor
- Summit Therapeutics
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-19
- Primary completion
- 2021-09-17
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.